{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:26:58Z","timestamp":1791883618548,"version":"4.3.4"},"reference-count":52,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The role of adenosine deaminase (ADA) in pulmonary tuberculosis (PTB) remains insufficiently defined in advanced forms of disease. Likewise, the systemic immune inflammatory index (SII) has not been validated in severe PTB. This 6-year prospective observational study aims to evaluate biomarker signatures of serum ADA and SII. Materials and Methods: According to the PTB case definition, 232 adult patients were divided into group 1, with a positive bacteriologic exam (n = 168), and group 2, without bacteriological confirmation (n = 64). ADA serum levels were compared by age, gender, nutritional status, morphologic and bacteriological pattern of PTB lesions, survival status, along with serum levels of other inflammatory biomarkers. All patients with comorbidities, interfering with the level of ADA, were excluded to avoid bias. Results: A total cohort of 208 PTB adults, aged 54.37 \u00b1 14.365 years, included 156 males. The overall mortality was 11.53%. Death occurred after a mean interval of 1.63 \u00b1 3.228 months after PTB diagnosis. ADA serum mean levels were 32.94 \u00b1 9.146 IU\/L, significantly higher in G1 (p = 0.002), in patients with delayed diagnosis of PTB (p = 0.000), with lung cavitation (p = 0.003), and death as a poor outcome (p \u02c2 0.02). SII had a mean value of 1752.226 \u00b1 2704.150, significantly increased in bacteriologically confirmed PTB cases (p = 0.018), delayed diagnosis (p = 0.002), cavitary advanced pulmonary tuberculosis (APT) (p = 0.002), and deceased (p = 0.003). Both an ADA cut-off elevated risk value of over 30 IU\/L and SII of over 902 were fulfilled by 73 patients, with 2.10 higher risk of advanced PTB (p = 0.006) and 4.49 higher risk of mortality (p = 0.000). Conclusions: Serum ADA and SII are recommended as predictors of advanced and severe pulmonary TB. These findings indicate that ADA and SII, when elevated together, delineate a high-risk PTB phenotype with greater disease severity and early mortality. The combination offers a pragmatic, biomarker-based approach to risk stratification in PTB.<\/jats:p>","DOI":"10.3390\/medicina61061096","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T03:37:07Z","timestamp":1750131427000},"page":"1096","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adenosine Deaminase and Systemic Immune Inflammatory Index\u2014A Biomarker Duet Signature of Pulmonary Tuberculosis Severity"],"prefix":"10.3390","volume":"61","author":[{"given":"Ioan Anton","family":"Arghir","sequence":"first","affiliation":[{"name":"Doctoral School of Medicine, \u201cOvidius\u201d University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Clinical Internal 4th Department, Medicine Faculty, \u201cOvidius\u201d University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Constanta Clinical Pneumology Hospital, 40 Sentinelei Str., 900002 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9844-8521","authenticated-orcid":false,"given":"Oana Cristina","family":"Arghir","sequence":"additional","affiliation":[{"name":"Doctoral School of Medicine, \u201cOvidius\u201d University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Constanta Clinical Pneumology Hospital, 40 Sentinelei Str., 900002 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-0562","authenticated-orcid":false,"given":"Marina Ruxandra","family":"Otelea","sequence":"additional","affiliation":[{"name":"Occupational Diseases Department, Medicine Faculty, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania"},{"name":"Occupational Department, Colentina Clinical Hospital, 19-21 Stefan cel Mare, 020125 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia Tania","family":"Andronache","sequence":"additional","affiliation":[{"name":"Internal Medicine Clinic, \u201cDr. Alexandru Gafencu\u201d Military Emergency Hospital, 96 Mamaia Blvd., 900527 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Ion","sequence":"additional","affiliation":[{"name":"Doctoral School of Medicine, \u201cOvidius\u201d University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Clinical Internal 4th Department, Medicine Faculty, \u201cOvidius\u201d University of Constanta, 1 University Alley, 900470 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"ref_1","unstructured":"WHO World Health Organization (2024). Global Tuberculosis Report 2024, World Health Organization. Available online: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Al Khatib, A., Hassanein, S., Almari, M., Koubar, M., and Fakhreddine, S. (2024). Tuberculosis morbidity and mortality during the COVID-19 pandemic: A life-threatening complex challenge. Front. Cell Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1423081"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.200901-0059OC","article-title":"Increasing proportions of advanced pulmonary tuberculosis reported in the United States: Are delays in diagnosis on the rise?","volume":"180","author":"Wallace","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100475","DOI":"10.1016\/j.jctube.2024.100475","article-title":"Advanced pulmonary tuberculosis in Alameda County: Ten-year incidence and risk factors","volume":"37","author":"Marusinec","year":"2024","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.5588\/ijtld.17.0413","article-title":"Increasing likelihood of advanced pulmonary tuberculosis at initial diagnosis in a low-incidence US state","volume":"22","author":"Yang","year":"2018","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_6","first-page":"259","article-title":"Patient, diagnosis, and treatment delays among tuberculosis patients before and during the COVID-19 epidemic\u2014China, 2018\u20132022","volume":"5","author":"Li","year":"2023","journal-title":"China CDC Wkly."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.46234\/ccdcw2024.221","article-title":"Patient delay in the diagnosis of pulmonary tuberculosis in the elderly\u2014China, 2015\u20132023","volume":"6","author":"Liu","year":"2024","journal-title":"China CDC Wkly."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3329\/akmmcj.v5i2.21132","article-title":"Adenosine deaminase in diagnosis of tuberculosis: A review","volume":"5","author":"Barua","year":"2014","journal-title":"Anwer Khan Mod. Med. Coll. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U","article-title":"Adenosine deaminase: Functional implications and different classes of inhibitors","volume":"21","author":"Cristalli","year":"2001","journal-title":"Med. Res. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5001\/omj.2013.118","article-title":"The diagnostic efficacy of adenosine deaminase in tubercular effusion","volume":"28","author":"Kelam","year":"2013","journal-title":"Oman Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/bmj.2.6154.1751-a","article-title":"Adenosine deaminase activity in pleural effusions: An aid to differential diagnosis","volume":"2","author":"Piras","year":"1978","journal-title":"Br. Med. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"300060520910042","DOI":"10.1177\/0300060520910042","article-title":"Serum proteomic analysis of Mycobacterium tuberculosis antigens for discriminating active tuberculosis from latent infection","volume":"48","author":"Peng","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.resinv.2023.04.010","article-title":"Current status and future landscaping of diagnosing tuberculosis infection","volume":"61","author":"Kobashi","year":"2023","journal-title":"Respir Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102169","DOI":"10.1016\/j.tube.2022.102169","article-title":"Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis","volume":"133","author":"Jacobs","year":"2022","journal-title":"Tuberculosis"},{"key":"ref_15","unstructured":"WHO World Health Organization (2013). Definitions and Reporting Framework for Tuberculosis\u20142013 Revision, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/79199\/9789241505345_eng.pdf."},{"key":"ref_16","unstructured":"WHO World Health Organization (2020). WHO Consolidated Guidelines on Tuberculosis, World Health Organization. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/331170\/9789240001503-eng.pdf."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Pasco, J.A., Holloway, K.L., Dobbins, A.G., Kotowicz, M.A., Williams, L.J., and Brennan, S.L. (2014). Body mass index and measures of body fat for defining obesity and underweight: A cross-sectional, population-based study. BMC Obes., 1.","DOI":"10.1186\/2052-9538-1-9"},{"key":"ref_18","unstructured":"Elia, M. (2003). The \u201cMUST\u201d Report. Nutritional Screening of Adults: A Multidisciplinary Responsibility, BAPEN."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ser\u00f3n-Arbeloa, C., Labarta-Monz\u00f3n, L., Puzo-Foncillas, J., Mallor-Bonet, T., Lafita-L\u00f3pez, A., Bueno-Vidales, N., and Montoro-Huguet, M. (2022). Malnutrition screening and assessment. Nutrients, 14.","DOI":"10.20944\/preprints202205.0071.v1"},{"key":"ref_20","first-page":"E143","article-title":"Tuberculosis: A timeless challenge for medicine","volume":"61","author":"Armocida","year":"2020","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cioboata, R., Biciusca, V., Olteanu, M., and Vasile, C.M. (2023). COVID-19 and tuberculosis: Unveiling the dual threat and shared solutions perspective. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144784"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101031","DOI":"10.1016\/j.cegh.2022.101031","article-title":"Tuberculosis and COVID-19: A combined global threat to human civilization","volume":"15","author":"Patra","year":"2022","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Alemu, A., Bitew, Z.W., Seid, G., Diriba, G., Gashu, E., Berhe, N., Mariam, S.H., and Gumi, B. (2022). Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0277807"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100278","DOI":"10.1016\/j.jctube.2021.100278","article-title":"Gaps related to screening and diagnosis of tuberculosis in East African health-care cascades: A retrospective study","volume":"25","author":"Mnyambwa","year":"2021","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Shah, H.D., Nazli-Khatib, M., Syed, Z.Q., Gaidhane, A.M., Yasobant, S., Narkhede, K., Bhavsar, P., Patel, J., Sinha, A., and Puwar, T. (2022). Gaps and interventions across the diagnostic care cascade of TB patients: A qualitative review. Trop. Med. Infect. Dis., 7.","DOI":"10.3390\/tropicalmed7070136"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.4081\/idr.2016.6568","article-title":"Tuberculosis biomarkers: From diagnosis to protection","volume":"8","author":"Goletti","year":"2016","journal-title":"Infect. Dis. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/CBF.S41651","article-title":"Improving tuberculosis diagnostics with biomarkers","volume":"5","author":"Shu","year":"2015","journal-title":"Curr. Biomark. Findings"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102518","DOI":"10.1016\/j.tube.2024.102518","article-title":"Flow cytometry-based cytokine profiling differentiates Mycobacterium tuberculosis infection from disease","volume":"147","author":"Dolezalova","year":"2024","journal-title":"Tuberculosis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e14088","DOI":"10.15252\/emmm.202114088","article-title":"Diagnostic biomarkers for active tuberculosis: Progress and challenges","volume":"14","author":"Nogueira","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1513\/AnnalsATS.201408-394OC","article-title":"Predicting tuberculosis with the tuberculin skin test and QuantiFERON testing","volume":"12","author":"Altet","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Matuku-Kisaumbi, P. (2025). The role of TB biomarkers in diagnosis, prognosis and prevention of tuberculosis. Infectious Diseases, IntechOpen.","DOI":"10.5772\/intechopen.115129"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Aggarwal, A.N., Agarwal, R., Sehgal, I.S., and Dhooria, S. (2019). Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0213728"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1080\/21691401.2019.1647221","article-title":"Sequential ADA screening and T-SPOT assay in pleural effusion patients","volume":"47","author":"Feng","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02872407","article-title":"Study of adenosine deaminase activity in pulmonary tuberculosis and other common respiratory diseases","volume":"19","author":"Verma","year":"2004","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Shaukat, S.N., Eugenin, E., Nasir, F., Khanani, R., and Kazmi, S.U. (2023). Identification of immune biomarkers in recent active pulmonary tuberculosis. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-38372-7"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Carabal\u00ed-Isajar, M.L., Rodr\u00edguez-Bejarano, O.H., Amado, T., Patarroyo, M.A., Izquierdo, M.A., Lutz, J.R., and Ocampo, M. (2023). Clinical manifestations and immune response to tuberculosis. World J. Microbiol. Biotechnol., 39.","DOI":"10.1007\/s11274-023-03636-x"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.56557\/ajmab\/2025\/v10i19351","article-title":"Biomarkers for tuberculosis diagnosis and monitoring: A review of translational progress","volume":"10","author":"Promise","year":"2025","journal-title":"Asian J. Microbiol. Biotech."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijtb.2017.08.001","article-title":"Role of serum adenosine deaminase in pulmonary tuberculosis","volume":"65","author":"Saini","year":"2018","journal-title":"Indian J. Tuberc."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Salmanzadeh, S., Tavakkol, H., Bavieh, K., and Alavi, S.M. (2015). Diagnostic value of serum adenosine deaminase in pulmonary tuberculosis. Jundishapur J. Microbiol., 8.","DOI":"10.5812\/jjm.21760"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.11599\/germs.2016.1090","article-title":"Diagnostic value of sputum adenosine deaminase in pulmonary tuberculosis","volume":"6","author":"Binesh","year":"2016","journal-title":"Germs"},{"key":"ref_42","first-page":"139","article-title":"Serum adenosine deaminase in sputum-negative pulmonary tuberculosis","volume":"38","author":"Agarwal","year":"1991","journal-title":"Indian J. Tuberc."},{"key":"ref_43","first-page":"CR476","article-title":"Course of serum adenosine deaminase in pulmonary tuberculosis","volume":"12","author":"Kartaloglu","year":"2006","journal-title":"Med. Sci. Monit."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/lungindia.lungindia_395_19","article-title":"Changes of serum adenosine deaminase before and after intensive-phase therapy in pulmonary tuberculosis","volume":"37","author":"Soedarsono","year":"2020","journal-title":"Lung India"},{"key":"ref_45","first-page":"e2023038","article-title":"Systemic immune-inflammation index in granulomatous versus reactive LAP diagnosed by endobronchial ultrasonography","volume":"40","author":"Kerget","year":"2023","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2478\/jccm-2022-0013","article-title":"Systemic immune-inflammation index and mortality in COVID-19 patients","volume":"8","author":"Karaaslan","year":"2022","journal-title":"J. Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/1687-8426.184369","article-title":"Serum adenosine deaminase for pulmonary tuberculosis diagnosis","volume":"10","author":"Alaarag","year":"2016","journal-title":"Egypt J. Bronchol."},{"key":"ref_48","first-page":"3449","article-title":"Serum adenosine deaminase in tuberculosis and inflammatory lung disease","volume":"26","author":"Gencheva","year":"2020","journal-title":"J. IMAB\u2014Annu. Proc. Sci. Pap."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Yu, Z., Shang, Z., Huang, Q., Wen, F., and Patil, S. (2024). Integrating systemic immune-inflammation index, fibrinogen and T-SPOT.TB for distinguishing active pulmonary tuberculosis. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1382665"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"\u015etefanescu, S., Coco\u015f, R., Turcu-Stiolica, A., Mahler, B., Meca, A.D., Giura, A.M.C., Bogdan, M., Shelby, E.S., Zamfirescu, G., and Pisoschi, C.G. (2021). Prognostic value of hematologic profiles after intensive-phase TB treatment in Romania. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249301"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e40349","DOI":"10.1097\/MD.0000000000040349","article-title":"Systemic immune-inflammation biomarkers predict drug-induced liver injury in HBV-positive TB patients","volume":"103","author":"Dong","year":"2024","journal-title":"Medicine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","article-title":"Receiver operating characteristic curve analysis in diagnostic accuracy studies: A guide to interpreting the area under the curve value","volume":"23","author":"Aksel","year":"2023","journal-title":"Turk. J. Emerg. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1096\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:53:16Z","timestamp":1760032396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medicina61061096"],"URL":"https:\/\/doi.org\/10.3390\/medicina61061096","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}